This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX Europe
Life Science Fundraising & Investment
24 March 2026 - Pre-day forums (Life Science Companies only), FIL (Feira Internacional de Lisboa)25-26 March 2026 - Main days, Lisbon Congress Centre, Lisbon, Portugal
Tickets
Menu
Tickets
keyboard_arrow_right

Day Two - Western European Summer Time (WEST)

keyboard_arrow_leftSearch & Filter
search
Day Two - Western European Summer Time (WEST)
search
Showing 1 of 1 Streams
11:35 - 12:15
Global Hotbeds of Innovation: Where Will the Next Breakthroughs Come From?
  • Mathias Frederiksen - Principal, Novartis Venture Fund
12:15 - 12:55
From Lab to Launch: How to Turn Academic Research into a Viable Biotech
  • Deborah Sterling - Director, Sterne Kessler
  • Marta Lesko - VP, Head of Neurology & Immunology Business Development, Merck KGaA
  • Laura Ferguson - Director, Platform Technologies Search and Evaluation, AstraZeneca
  • Michel de Baar - Executive Director, Business Development, Europe, Merck
  • Johan Juhlin - CEO, Mavatar
Showing 1 of 1 Streams
14:05 - 14:55
Rare Diseases vs. Broad Indications: Where to Focus Early-Stage Innovation
  • Lori Badura - Head of Global Partnering Rare Disease & Neuroscience, IPSEN
  • Sten Sörensen - CEO, Cereno Scientific
14:55 - 15:45
Next-Gen Modalities: Beyond Antibodies and Small Molecules
  • Christopher Church - Head of Technology Search & Evaluation, Biopharmaceuticals R&D, AstraZeneca
  • Hiroyuki Usuda - Scouting & Innovation Management Manager, Astellas Innovation Management LLC
  • Jonas Båtelson - CEO, Curacell
Day One - Pre-Day
NextDay Two Showcases
Filter
Streams
Clear
Formats
Choose Day